The Biochemical Society is concerned at the growing rate of antimicrobial resistance. We believe that sustained research funding is needed to drive the development of new antimicrobials and alternative approaches to combating infection, particularly vaccines. The development of rapid diagnostics will also be vital.
Read our Antimicrobial Resistance position statement.
Learned Society Partnership on Antimicrobial Resistance
Biochemical Society is part of the Learned Society Partnership on Antimicrobial Resistance (LeSPAR) in collaboration with the Royal Society of Biology, the British Society for Antimicrobial Chemotherapy, the British Pharmacological Society, the Microbiology Society, the Royal Society of Chemistry, and the Society for Applied Microbiology.
LeSPAR aims to provide a single, unified voice and mobilise the UK’s collective research community in order to enhance understanding and knowledge sharing between academia, industry, and clinicians. The group is focused on taking action, championing best practice and raising awareness of the global challenge of antimicrobial resistance.
A report and an executive summary have been published in September 2015 on the three networking workshops which looked into the antimicrobial resistance environments, evolution and transmission earlier this year. The talks from the workshops can be viewed online.